TLSA
Tiziana Life Sciences Ltd. Common SharesRecent alerts on TLSA
All signals →
SEC filing
TLSA Completes Enrollment in Phase 2a Trial of Intranasal Foralumab for Non-Active Secondary Progressive Multiple Sclerosis, 48 Patients Enrolled
12d ago
News
Tiziana says updated data for multiple sclerosis therapy shows long-term safety
14d ago
SEC filing
TLSA Reports Positive Clinical Data for Intranasal Foralumab, 64% of Patients Show Clinically Meaningful Fatigue Improvement, Favorable EDSS Stabilization Trend
14d ago
SEC filing
TLSA Reports Positive Preclinical Data on Intranasal Anti-CD3 for Long COVID Brain Fog, Shows Neuroinflammation Reduction and Cognitive Improvement in Mouse Model, Co-Authored by Yale’s Iwasaki and Harvard’s Weiner, Study Published on bioRxiv, Highlights Potential for Non-Invasiv
47d ago
News
Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares
136d ago
News
Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares
136d ago
News
Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $17.6 Million
137d ago
Scanner
Unusual volume (z=5.5)
168d ago
News
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
168d ago
Scanner
Unusual volume (z=5.7)
169d ago
Scanner
Unusual volume (z=5.7)
170d ago
Scanner
Unusual volume (z=5.7)
171d ago
Get push alerts for TLSA
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS